Related Experiment Videos

Update of the NCCN guidelines for treatment of prostate cancer

R Millikan¹, C Logothetis

¹Dept. of Genito-urinary Medical Oncology, UT M. D. Anderson Cancer Center, Houston, Texas, USA.

Oncology (Williston Park, N.Y.)

|January 16, 1998

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration-resistant prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases.

European journal of cancer (Oxford, England : 1990)·2017

Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties.

Oncogene·2016

Response in bone turnover markers during therapy predicts overall survival in patients with metastatic prostate cancer: analysis of three clinical trials.

British journal of cancer·2012

Clinical significance of elevation in neuroendocrine factors and interleukin-6 in metastatic prostate cancer.

Urologic oncology·2011

Maximum likelihood estimation of haplotype effects and haplotype-environment interactions in association studies.

Genetic epidemiology·2005

See all related articles